🇺🇸 Trametinib tablet in United States

43 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pyrexia — 12 reports (27.91%)
  2. Chills — 7 reports (16.28%)
  3. Squamous Cell Carcinoma — 4 reports (9.3%)
  4. Alanine Aminotransferase Increased — 3 reports (6.98%)
  5. Aspartate Aminotransferase Increased — 3 reports (6.98%)
  6. Diarrhoea — 3 reports (6.98%)
  7. Nausea — 3 reports (6.98%)
  8. Squamous Cell Carcinoma Of Skin — 3 reports (6.98%)
  9. Vomiting — 3 reports (6.98%)
  10. Abdominal Pain — 2 reports (4.65%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Trametinib tablet approved in United States?

Trametinib tablet does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Trametinib tablet in United States?

West China Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.